As of March 2017, there are more than 3.1 million women with a history of breast cancer in the U.S. This includes women currently being treated and women who have finished treatment.
The most common cancer for women throughout the world is breast cancer. The best way to raise the survival rates in these patients is early detection. Although there are different treatments available for neutralization of tumors, more than 520,000 women died from breast cancer only in 2016.
The European Breast Cancer Conference in Amsterdam included the presentation of one research by the Cancer Research UK-funded trial, which shows that a pair of drugs can eliminate certain types of breast cancer in only eleven days. According to the new finding, some women with breast cancer might never need chemo.
The two drugs Lapatinib and Herceptin are commonly used in the treatment of one type of breast cancer, following tumor-removal surgery and chemo. The trial analyzed their effects, and discovered that they both target HER2- protein that drives growth of some types of breast cancer, even the aggressive variants.
The research included 257 women with HER2- positive breast cancer who received the two drugs right before they needed surgery. In a period of two weeks, 11% of the cancers have completely disappeared, while 17% have shrunken.
Researchers were shocked that this drug combination could in some cases completely cure breast cancer patients. This study is small but important for breast cancer sufferers, as HER2-fueled breast cancers have more chances to return than others.
Although temporarily, the conventional chemo is followed by many debilitating side effects, like strong fatigue, frequent vomiting, hair loss, and sometimes decreased cognitive functions. It can last up to several months, but even then, it might not cure the cancer patient. The new finding shows that some breast cancer sufferers might not need chemo, or surgery to start with.
According to Guardian, the chief executive Samia al Qadhi of the UK-based charity- Breast Cancer Care, believes that although it’s an early-stage research, it has the potential to change everything. She says that currently, Herceptin is only available to be used alongside chemo, but not alone. All cancer sufferers deserve access to medically effective treatments.
Breast cancer is considered as a group of at least 10 separate diseases, all of which have their own development style. Although there’s a long way to go until all 10 diseases are comprehensively and quickly cured, studies and researches like this one are beneficial for medical professionals, providing them with another effective weapon in their arsenal.
We really hope you find this article helpful and don’t forget to share it with your friends and family. Thank You.